Showing results (61-70 of 132) with videos related to

Sort By:
Pageof 14
Internal Medicine (Tokyo, Japan)|November 17, 2015
Nanoparticle Albumin-bound Paclitaxel+Carboplatin Therapy for Small Cell Lung Cancer Combined with Squamous Cell Carcinoma and Interstitial Lung DiseaseYuichiro Azuma, Motohiro Tamiya, Takayuki Shiroyama, et al.
Anticancer Research|November 2, 2010
Cytokeratin 19 fragment/carcinoembryonic antigen ratio in pleural effusion is a useful marker for detecting malignant pleural mesotheliomaHidekazu Suzuki, Tomonori Hirashima, Masashi Kobayashi, et al.
Respirology (Carlton, Vic.)|April 17, 2013
Diagnostic yield of combined bronchoscopy and endobronchial ultrasonography, under LungPoint guidance for small peripheral pulmonary lesionsMotohiro Tamiya, Norio Okamoto, Shinji Sasada, et al.
Internal Medicine (Tokyo, Japan)|March 23, 2011
Diagnostic factors of standard bronchoscopy for small (≤15 mm) peripheral pulmonary lesions: a multivariate analysisMotohiro Tamiya, Shinji Sasada, Masashi Kobayashi, et al.
Respiratory Medicine Case Reports|November 30, 2016
Successful retreatment with osimertinib after osimertinib-induced acute pulmonary embolism in a patient with lung adenocarcinoma: A case reportTakayuki Shiroyama, Manabu Hayama, Shingo Satoh, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 19, 2008
[Two cases of severe myelosuppression from amrubicin in previously-treated small cell lung cancer]Hidekazu Suzuki, Shinji Sasada, Yoshinobu Matsuda, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 25, 2010
[Renal salt-wasting syndrome progressing to severe hyponatremia after chemotherapy--a case report]Hidekazu Suzuki, Tomonori Hirashima, Masashi Kobayashi, et al.
Anticancer Research|March 31, 2021
Extracellular Water-to-total Body Water Ratio as an Objective Biomarker for Frailty in Lung Cancer PatientsTomonori Hirashima, Yoshimi Noda, Hidekazu Suzuki, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|March 1, 2012
Serum HE4 as a diagnostic and prognostic marker for lung cancerKota Iwahori, Hidekazu Suzuki, Yoshiro Kishi, et al.
Chinese Journal of Cancer|December 15, 2012
The relationship between tyrosine kinase inhibitor therapy and overall survival in patients with non-small cell lung cancer carrying EGFR mutationsHidekazu Suzuki, Tomonori Hirashima, Norio Okamoto, et al.
Pageof 14